WORLDWIDE M&A, net competing bids, has increased 48% compared to YTD 2013
This week's $5.3 billion bid for US-based Questcor Pharmaceuticals from Mallinckrodt PLC and the $3.9 billion offer for Ranbaxy Laboratories by Sun Pharmaceuticals brings global deal making in the healthcare sector to $64.1 billion this year, nearly triple the level of activity last year at this time and best annual start for M&A in the sector since 2009. The United States, India and China account for 92% of year-to-date activity, up from 60% a year ago.
The $40.1 billion merger of equals between Switzerland's Holcim Ltd and France's Lafarge SA ranks as the largest M&A deal in Europe since Glencore's $45.8 billion bid for Xstrata in February 2012. European M&A activity totals $253.1 billion for year-to-date 2014, an increase of 85% compared to a year ago
Just the third high yield issuer to raise over $5 billion over the past two years, Wind Acquisition Finance's $5.2 billion high yield corporate bond offering pushes global high yield issuance to $146.5 billion on par with last year's issuance levels
Global IPO activity reaches $56.9 billion so far during 2014, more than double last year's tally and the best year-to-date since 2000
This week's $2.1 billion follow-on offering from Spain's Iberdrola SA and a $1.3 offering from RSA Insurance Group PLC of the United Kingdom pushed year-to-date follow-on activity from companies in Europe to $53.3 billion, up 52% compared to a year ago and the strongest year-to-date since records began in 1980
Goldman Sachs tops the ranking of European follow-on underwriters, with 15.9% market share, followed by UBS with 12.2% and JP Morgan with 10.0 market share.